Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 153 publications
Erratum: Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 03, 2026
Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 29, 2026
Long-Term Outcomes of Mayo Stage IIIb AL Amyloidosis Treated With Daratumumab-Based Frontline Therapy.
Journal: American journal of hematology
Published: May 04, 2026
Use of CD38 Antibodies in High-Risk Newly Diagnosed Multiple Myeloma: A Meta-Analysis.
Journal: Clinical lymphoma, myeloma & leukemia
Published: March 16, 2026
A Clinically Applicable Conversion Formula between NT-proBNP and BNP in Light-Chain Amyloidosis.
Journal: JACC. CardioOncology
Published: March 16, 2026
1F10, a λ Light Chain Amyloid-Specific Monoclonal Antibody for Targeted Therapy of AL Amyloidosis.
Journal: Blood
Published: February 02, 2026
Integrating an updated high-risk multiple myeloma classification into clinical practice and clinical trial epidemiology.
Journal: Expert review of hematology
Published: January 27, 2026
Predicting Early Mortality in Newly Diagnosed AL Amyloidosis: Development and Validation of the PACE Score for Daratumumab-Treated Patients.
Journal: American journal of hematology
Published: January 20, 2026
Autologous stem cell transplantation for AL amyloidosis: a multicenter summary of outcomes 2010-2020.
Journal: Bone marrow transplantation
Published: December 18, 2025
Endless possibilities and how to exploit them? What is the optimal treatment sequence?
Journal: Hematology. American Society of Hematology. Education Program
Published: December 05, 2025
Treatment response assessment using whole body diffusion weighted-magnetic resonance imaging in myeloma: a retrospective cohort study.
Journal: Leukemia & lymphoma
Published: November 11, 2025
Zanubrutinib in AL Amyloidosis Associated With Waldenström Macroglobulinemia and Other B-Cell Non-Hodgkin Lymphoma.
Journal: American journal of hematology
Published: November 01, 2025
Last Updated: 09/26/2026